glp 1 parkinson's GLP-1 drug shows little benefit for people with disease | UCL News Beyond insulin: The Intriguing role

Focusing on what you can control now will serve you in the long run, too

Further research has also confirmed this

Downstream molecules of this pathway such as forkhead box protein O (FoxO), mechanistic target of rapamycin (mTOR) and glycogen synthase kinase 3 (GSK3) are implicated in processes such as -synuclein degradation, mitochondrial biogenesis, oxidative stress and inflammation all being of crucial importance in PD pathogenesis

And am I a candidate for medication like this

To learn more about the complex science behind metabolic health and the effective application of modern therapeutics, the Certificate Program in Nutrition Strategies for Lifelong Health and Wellness offered by Duke University School of Medicine provides a rigorous, evidence-based foundation

10.1001/jamaneurol.2022.1375 JAMA Neurol